Wheeler, DC;
Jongs, N;
Stefansson, BV;
Chertow, GM;
Greene, T;
Hou, FF;
Langkilde, AM;
... DAPA-CKD Trial Committees and Investigators; + view all
(2021)
Safety and efficacy of dapagliflozin in patients with focal segmental glomerulosclerosis: A prespecified analysis of the DAPA-CKD trial.
Nephrology Dialysis Transplantation
10.1093/ndt/gfab335.
(In press).